LASSO regression-based nomogram for distinguishing nontuberculous mycobacterial pulmonary disease from pulmonary tuberculosis: a clinical risk prediction model

基于 LASSO 回归的列线图用于区分非结核分枝杆菌肺病和肺结核:一种临床风险预测模型

阅读:1

Abstract

This study aims to identify predictive factors that can effectively distinguish between non-tuberculous mycobacterial pulmonary disease (NTM-PD) and pulmonary tuberculosis (PTB) by comparing their clinical characteristics and laboratory indicators, and to construct a risk prediction model based on these factors to improve the accuracy of clinical diagnosis, optimize treatment strategies, and reduce the risks of misdiagnosis and drug resistance. Data from 150 hospitalized patients treated at The Second People's Hospital of Fuyang City between January 2021 and December 2022 were collected, including 50 cases with NTM-PD and 100 cases with PTB. By gathering clinical data and laboratory inflammation markers of the patients, key predictive factors were identified using LASSO regression. These factors were further analyzed through univariate and multivariate logistic regression analysis to determine the influencing factors of NTM-PD, thereby constructing a nomogram prediction model. The accuracy of the model was evaluated through calibration curves, ROC curves, and Hosmer-Lemeshow goodness-of-fit tests, while its clinical utility was assessed using decision curve analysis and clinical impact curves.The two groups showed significant differences in age, BMI, bronchiectasis, and lung cavitation (P < 0.05). LASSO regression analysis identified age, BMI, bronchiectasis, and lung cavitation as four key variables. Multivariate logistic regression analysis revealed that old age, bronchiectasis, and lung cavitation were risk factors for NTM-PD, while low BMI acted as a protective factor. The nomogram model constructed based on these four variables demonstrated excellent predictive performance. The Hosmer-Lemeshow goodness-of-fit test indicated good model fit (P = 0.448), with an area under the ROC curve (AUC) of 0.861 (95% CI: 0.798-0.923). Decision curve and clinical impact curve analyses suggested that the model has the potential to optimize clinical decision-making within a threshold probability range of 0.05 to 0.75. By analyzing the critical differential characteristics between NTM-PD and PTB, we successfully developed a prediction model based on age, BMI, bronchiectasis, and lung cavitation, which effectively assesses the risk of NTM-PD occurrence, providing clinicians with a practical diagnostic aid.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。